Moki Chris Usani*

Elizabeth Glaser Pediatric Aids Foundation, Ministry of Public Health, Biaka University Institute Buea, Cameroon

*Corresponding Author: Moki Chris Usani, Elizabeth Glaser Pediatric Aids Foundation, Ministry of Public Health, Biaka University Institute Buea, Cameroon.

Received: December 07, 2021; Published: March 10, 2022

Abstract

Not long after the corona virus introduced itself in Wuhan, China, with all the subtlety and finesse of a bull in a China shop, efforts towards creating and distributing a vaccine reached fever pitch. In fact, just a few months after the World Health Organization (WHO) declared COVID-19 a pandemic (on March 11, 2020), two major pharmaceutical and biotech giants: Pfizer (in partnership with BioNTech) and Moderna, Inc., announced their success following the primary efficacy analyses of their phase 3 COVID-19 vaccine trials.

Keywords: COVID-19; World Health Organization (WHO); Wuhan

References

1. “U.S. Food and Drug Administration”. Maryland: FDA (2020).
2. “U.S. Food and Drug Administration”. Maryland: FDA (2020).
3. “U.S. Food and Drug Administration”. Maryland: FDA (2021).
4. Zimmer C., et al. “Corona Virus Vaccine Tracker”. New York: New York Times (2021).
5. MacDonald N E and SAGE Working Group on Vaccine Hesitancy. “Vaccine hesitancy: Definition, scope and determinants”. Vaccine34 (2015): 4161-4164.
6. Coustasse Alberto., et al. “COVID-19 and Vaccine Hesitancy”. Journal of Ambulatory Care Management1 (2021): 71-75.
7. org. “The History of Vaccines”. Philadelphia: An Educational Resource by the College of Physicians of Philadelphia (2018).
8. McAteer J., et al. “The VACCINES Act: Deciphering Vaccine Hesitancy in the Time of COVID-19”. Clinical Infectious Diseases 15 (2020): 703-705.
9. “U.S. Center for Disease Control”. Georgia: CDC (2021).
10. “U.S. Center for Disease Control”. Georgia: CDC (2021).
11. “U.S. Center for Disease Control”. Georgia: CDC (2021).
12. “U.S. Center for Disease Control”. Georgia: CDC (2021).
13. “U.S. Center for Disease Control”. Georgia: CDC (2021).
14. Polack FP., et al. “Safety and efficacy of the BNT162b2 mRNA COVID-19 Vaccine”. The New England Journal of Medicine 383 (2020): 2603-2615.
15. “U.S. National Institute of Health”. Maryland: NIH (2021).
16. “U.S. National Institute of Health”. Maryland: NIH (2020).
17. “Moderna”. (2021).
18. “U.S. Food and Drug Administration”. Maryland: FDA (2020).

Citation

Citation: Moki Chris Usani. “Misinformation and COVID Vaccine Hesitancy: The Viral Threat to COVID Vaccine Efficacy”.Acta Scientific Medical Sciences 6.4 (2022): 57-63.

Copyright

Copyright: © 2022 Moki Chris Usani. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.